Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
1999-09-09
2004-02-24
Caputa, Anthony C. (Department: 1642)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
Reexamination Certificate
active
06696558
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates generally to the fields of molecular biology and molecular medicine and more specifically to a novel family of proteins that can regulate protein folding. The functions of these proteins are potentially diverse, including promoting tumor cell growth and metastasis.
2. Background Information
The Hsc70/Hsp70-family of molecular chaperones participate in protein folding reactions, controlling protein bioactivity, degradation, complex assembly/disassembly, and translocation across membranes. These proteins interact with hydrophobic regions within target proteins via a carboxyl (C)-terminal peptide binding domain, with substrate binding and release being controlled by the N-terminal ATP-binding domain of Hsc70/Hsp70. Hsc70/Hsp70-assisted folding reactions are accomplished by repeated cycles of peptide binding, refolding, and release, which are coupled to ATP hydrolysis by the ATP-binding domain (ATPase) of Hsc70/Hsp70 and by subsequent nucleotide exchange. The chaperone activity of mammalian Hsc70/Hsp70 is regulated by partner proteins that either modulate the peptide binding cycle or that target the actions of these chaperones to specific proteins and subcellular compartments. DnaJ-family proteins (Hdj-1/Hsp40; Hdj-2; Hdj-3) stimulate the ATPase activity of Hsc70/Hsp70, resulting in the ADP-bound state which binds tightly to peptide substrates. The Hip protein collaborates with Hsc70/Hsp70 and DnaJ homologues in stimulating ATP hydrolysis, and thus also stabilize Hsc70/Hsp70 complexes with substrate polypeptides, whereas the Hop protein may provide co-chaperone functions through interactions with the C-terminal peptide binding domain.
The Bcl-2 associated athanogene-1 (bag-1) is named from the Greek word athanos, which refers to anti-cell death. BAG-1 was previously referred to as Bcl-2-associated protein-1 (BAP-1) in U.S. Pat. No. 5,539,094 issued Jul. 23, 1996, which is incorporated herein by reference. In this earlier patent, BAG-1 is described as a portion of the human BAG-1 protein, absent the N-terminal amino acids 1 to 85. In addition, a human protein essentially identical to human BAG-1 was described by Zeiner and Gehring, (
Proc. Natl. Acad. Sci., USA
92:11465-11469 (1995)). Subsequent to the issuance of U.S. Pat. No. 5,539,094 the N-terminal amino acid sequence from 1 to 85 of human BAG-1 was reported.
BAG-1 and its longer isoforms BAG-1M (Rap46) and BAG-1L are recently described Hsc70/Hsp70-regulating proteins. BAG-1 competes with Hip for binding to the Hsc70/Hsp70 ATPase domain and promotes substrate release. BAG-1 also reportedly stimulates Hsc70-mediated ATP hydrolysis by accelerating ADP/ATP exchange, analogous to the prokaryotic GrpE nucleotide exchange protein of the bacterial Hsc70 homologue, DnaK. Gene transfection studies indicate that BAG-1 proteins can influence a wide variety of cellular phenotypes through their interactions with Hsc70/Hsp70, including increasing resistance to apoptosis, promoting cell proliferation, enhancing tumor cell migration and metastasis, and altering transcriptional activity of steroid hormone receptors.
Despite the notable progress in the art, there remains an unmet need for the further identification and isolation of additional homologous BAG protein species, and the nucleic acid molecules and/or nucleotide sequences that encode them. Such species would provide additional means by which the identity and composition of the BAG domain, that is, the portion of the protein that is influencing or modulating protein folding, could be identified. In addition, such species would be useful for identifying agents that modulate apoptosis as candidates for therapeutic agents, in particular, anticancer agents. The present invention satisfies these need, as well as providing substantial related advantages.
SUMMARY OF THE INVENTION
The present invention provides a family of BAG-1 related proteins from humans [BAG-1L (SEQ ID NO:2), BAG-1 (beginning at residue 116 of SEQ ID NO:2), BAG-2 (SEQ ID NO: 4), BAG-3 (SEQ ID NO:6) and (SEQ ID NO:20), BAG-4 (SEQ ID NO:8) and (SEQ ID NO:22) and BAG-5 (SEQ ID NO:10) and (SEQ ID NO:24)], the invertebrate
C. elegans
[BAG-1 (SEQ ID NO:12), BAG-2 (SEQ ID NO:14)] and the fission yeast
S. pombe
[BAG-1A (SEQ ID NO:16), BAG-1B (SEQ ID NO:18)] and the nucleic acid molecules that encode them.
Another aspect of the present invention provides an amino acid sequence present in the family of BAG-1 related proteins, that modulates Hsc70/Hsp70 chaperone activity, that is, the BAG domain.
Another aspect of the present invention provides novel polypeptide and nucleic acid compositions and methods useful in modulating Hsc70/Hsp70 chaperone activity.
Another aspect of the present invention is directed to methods for detecting agents that modulate the binding of the BAG family of proteins, such as BAG-1 (beginning at residue 116 of SEQ ID NO:2), and related proteins with the Hsc70/Hsp70 Family of proteins or with other proteins that may interact with the BAG-Family proteins.
Still another aspect of the present invention is directed to methods for detecting agents that induce the dissociation of a bound complex formed by the association of BAG-Family proteins with Hsc70/Hsp70 Family molecule chaperones or other proteins.
REFERENCES:
patent: 5539094 (1996-07-01), Reed et al.
patent: 5650491 (1997-07-01), Reed et al.
patent: 5652223 (1997-07-01), Kohn et al.
patent: WO 95/13292 (1995-05-01), None
patent: WO-95/13292 (1995-05-01), None
Kozak M. EMBO J. May 1, 1997;16(9):2482-92.*
Grunert et al. EMBO J. Aug. 1, 1994;13(15):3618-30.*
Zeiner et al. Proc Natl Acad Sci USA. Dec. 5, 1995; 92 (25): 11465-9.*
Search Report us—09-394-142b-2.rge, pp. 3 and 4; see result 3.*
Takayama, S, Direct Submission, Sep. 03, 1997, Database GenBank Accession No. AF022224,Homo sapiensBcl-2-binding protein (BAG-1) mRNA, complete cds; see USPTO Search Report Results of US-09-394-142b-2_copy_1_85.rge (result 2).*
Takayama, S, Direct Submission, Sep. 03, 1997, Database GenBank Accession No. AF022224,Homo sapiensBcl-2-binding protein (BAG-1) mRNA, complete cds; see USPTO Search Report Results of US-09-394-142b-2_copy_57_89.rge (result 2).*
Takayama, S, Direct Submission, Sep. 03, 1997, Database GenBank Accession No. AF022224,Homo sapiensBcl-2-binding protein (BAG-1) mRNA, complete cds; see USPTO Search Report Results of US-09-394-142b-1_copy_272_319.rge (result 2).*
Takayama, S, Direct Submission, Sep. 03, 1997, Database GenBank Accession No. AF022224,Homo sapiensBcl-2-binding protein (BAG-1) mRNA, complete cds; see USPTO Search Report Results of US-09-394-142b-1_copy_46_1291.rge (result 1).*
Zeiner, M, Direct Submission, Jul. 28, 1994, Database GenBank Accession No. Z35491,H. sapiensmRNA for novel glucocorticoid receptor-associated protein; see USPTO Search Report US-09-394-142b-2_copy_1_85.rge, result 4.*
Hillier, L, et al, Unpublished, 1997, Database GenBank EST Accession No. AI815738, au43g01.y1 Schneider fetal brain 00004Homo sapienscDNA clone IMAGE:2517552, 5′similar to TR:075315; see USPTO Search Report US-09-394-142b-2_copy_1_85, result 1.*
Zeiner, M, Direct Submission, Jul. 28, 1994, Database GenBank Accession No. Z35491,H. sapiensmRNA for novel glucocorticoid receptor-associated protein; see USPTO Search Report US-09-394-142b-2_copy_57_89.rge, result 4.*
Hillier, L, et al, Unpublished, 1997, Database GenBank EST Accession No. AI815738, au43g01.y1 Schneider fetal brain 00004Homo sapienscDNA clone IMAGE:2517552, 5′ similar to TR:075315; see USPTO Search Report US-09-394-142b-2_copy_57_89, result 2.*
Zeiner, M, Direct Submission, Jul. 28, 1994, Database GenBank Accession No. Z35491,H. sapiensmRNA for novel glucocorticoid receptor-associated protein; see USPTO Search Report US-09-394-142b-1_copy_272_8319.rge, result 4.*
Hillier, L, et al, Unpublished, 1997, Database GenBank EST Accession No. AI815738, au43g01.y1 Schneider fetal brain 00004Homo sapienscDNA clone IMAGE:2517552, 5′ similar to TR:075315; see USPTO Search Report
Reed John C.
Takayama Shinichi
Caputa Anthony C.
Rawlings Stephen L.
The Burnham Institute
LandOfFree
Bag proteins and nucleic acid molecules encoding them does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bag proteins and nucleic acid molecules encoding them, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bag proteins and nucleic acid molecules encoding them will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3290448